BridgeMD
New treatment option for Breast Cancer
Official title What is the Best Interval to Screen Women 45-49 and 70-74 for Breast Cancer?
ClinicalTrials.gov ID: NCT04590560
What this study is testing
- What it's testing
- Italian, multicenter, study aimed at defining the best interval for screening women 45-49 and 70-74 years for Breast Cancer (BC). This research project includes (1) a controlled, prospective randomized non-inferiority trial to determine the optimal screening interval for women aged 45-49, with and without high mammographic density, (2) a retrospective data collection, with the same purpose, on screening performed by women aged 70-74, and (3) a qualitative research to define the best communication strategy.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 49, women only
You may be able to join if
- Women invited for their first or second mammography (45 or 46 y/o) presenting for screening;
- Willingness and ability to comply with scheduled visits;
- Written informed consent obtained prior to performing any protocol-related procedures.
You likely can't join if
- Pregnancy status;
- Personal history of prior breast carcinoma, either invasive or ductal carcinoma in situ (DCIS) diagnosis;
- Ascertained heredo-familial risk according to the standard family history used in screening programs;
- Participation in another clinical trial on BC screening;
- Inability to provide signed informed consent.
The study team makes the final eligibility decision.
Where it's taking place
- Meldola (FC), FC, Italy
- Florence, Italy
- Forlì, Italy
- Torino, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 45 years to 49 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Meldola (FC), FC, Italy; Florence, Italy; Forlì, Italy; Torino, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.